[go: up one dir, main page]

SE9503476D0 - New combination - Google Patents

New combination

Info

Publication number
SE9503476D0
SE9503476D0 SE9503476A SE9503476A SE9503476D0 SE 9503476 D0 SE9503476 D0 SE 9503476D0 SE 9503476 A SE9503476 A SE 9503476A SE 9503476 A SE9503476 A SE 9503476A SE 9503476 D0 SE9503476 D0 SE 9503476D0
Authority
SE
Sweden
Prior art keywords
pct
pharmaceutically acceptable
sec
new combination
acceptable salt
Prior art date
Application number
SE9503476A
Other languages
English (en)
Swedish (sv)
Inventor
Arne Eek
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9503476A priority Critical patent/SE9503476D0/xx
Publication of SE9503476D0 publication Critical patent/SE9503476D0/xx
Priority to DE69631597T priority patent/DE69631597T2/de
Priority to CA002233677A priority patent/CA2233677C/en
Priority to PCT/SE1996/001248 priority patent/WO1997012634A1/en
Priority to AU72335/96A priority patent/AU706794B2/en
Priority to PT96933709T priority patent/PT862462E/pt
Priority to US08/765,133 priority patent/US5908847A/en
Priority to ES96933709T priority patent/ES2214548T3/es
Priority to EP96933709A priority patent/EP0862462B1/en
Priority to DK96933709T priority patent/DK0862462T3/da
Priority to JP51420397A priority patent/JP4135977B2/ja
Priority to AT96933709T priority patent/ATE259657T1/de
Priority to NZ319746A priority patent/NZ319746A/xx
Priority to NO19981222A priority patent/NO318387B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
SE9503476A 1995-10-06 1995-10-06 New combination SE9503476D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9503476A SE9503476D0 (sv) 1995-10-06 1995-10-06 New combination
NZ319746A NZ319746A (en) 1995-10-06 1996-10-03 A synergisitic combination of a beta-receptor blocker and an opioid
US08/765,133 US5908847A (en) 1995-10-06 1996-10-03 Combination of a β-receptor blocker and an opioid
CA002233677A CA2233677C (en) 1995-10-06 1996-10-03 A novel combination of a .beta.-receptor blocker and an opioid
PCT/SE1996/001248 WO1997012634A1 (en) 1995-10-06 1996-10-03 A NOVEL COMBINATION OF A β-RECEPTOR BLOCKER AND AN OPIOID
AU72335/96A AU706794B2 (en) 1995-10-06 1996-10-03 A novel combination of a beta-receptor blocker and an opioid
PT96933709T PT862462E (pt) 1995-10-06 1996-10-03 Uma nova combinacao de um bloqueador de receptores beta e de um opioide
DE69631597T DE69631597T2 (de) 1995-10-06 1996-10-03 Kombination aus einem beta rezeptorblocker und einem opioid
ES96933709T ES2214548T3 (es) 1995-10-06 1996-10-03 Combinacion de un bloqueante de los beta-receptores y un opioide.
EP96933709A EP0862462B1 (en) 1995-10-06 1996-10-03 Combination of a beta-receptor blocker and an opioid
DK96933709T DK0862462T3 (da) 1995-10-06 1996-10-03 Kombination af en beta-receptorblokker og et opioid
JP51420397A JP4135977B2 (ja) 1995-10-06 1996-10-03 β−受容体遮断薬とオピオイドとの新規な組合せ物
AT96933709T ATE259657T1 (de) 1995-10-06 1996-10-03 Kombination aus einem beta rezeptorblocker und einem opioid
NO19981222A NO318387B1 (no) 1995-10-06 1998-03-18 Anvendelse av en kombinasjon av en beta-reseptorblokker og et opioid ved behandling av smerte.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9503476A SE9503476D0 (sv) 1995-10-06 1995-10-06 New combination

Publications (1)

Publication Number Publication Date
SE9503476D0 true SE9503476D0 (sv) 1995-10-06

Family

ID=20399727

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9503476A SE9503476D0 (sv) 1995-10-06 1995-10-06 New combination

Country Status (14)

Country Link
US (1) US5908847A (no)
EP (1) EP0862462B1 (no)
JP (1) JP4135977B2 (no)
AT (1) ATE259657T1 (no)
AU (1) AU706794B2 (no)
CA (1) CA2233677C (no)
DE (1) DE69631597T2 (no)
DK (1) DK0862462T3 (no)
ES (1) ES2214548T3 (no)
NO (1) NO318387B1 (no)
NZ (1) NZ319746A (no)
PT (1) PT862462E (no)
SE (1) SE9503476D0 (no)
WO (1) WO1997012634A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100306707B1 (ko) * 1998-09-07 2003-01-24 한국전기통신공사 교차이득변조형반도체광파장변환기
US7041365B2 (en) * 2003-05-12 2006-05-09 3M Innovative Properties Company Static dissipative optical construction
US8716350B2 (en) 2010-03-30 2014-05-06 Algynomics Inc. Compositions and methods for the treatment of somatosensory disorders
EP2552433A4 (en) * 2010-03-30 2013-11-06 Algynomics Inc COMPOSITIONS AND METHODS OF TREATING SOMATOSENSORY DISEASES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities

Also Published As

Publication number Publication date
EP0862462A1 (en) 1998-09-09
CA2233677C (en) 2006-08-29
JPH11513386A (ja) 1999-11-16
ES2214548T3 (es) 2004-09-16
AU706794B2 (en) 1999-06-24
US5908847A (en) 1999-06-01
EP0862462B1 (en) 2004-02-18
DE69631597T2 (de) 2004-12-16
DK0862462T3 (da) 2004-05-10
NO981222D0 (no) 1998-03-18
NO981222L (no) 1998-03-18
AU7233596A (en) 1997-04-28
NO318387B1 (no) 2005-03-14
ATE259657T1 (de) 2004-03-15
JP4135977B2 (ja) 2008-08-20
DE69631597D1 (de) 2004-03-25
CA2233677A1 (en) 1997-04-10
WO1997012634A1 (en) 1997-04-10
PT862462E (pt) 2004-06-30
NZ319746A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
AU8659901A (en) Active agent delivery systems and methods for protecting and administering active agents
AU2003268144A1 (en) Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
HU9203779D0 (en) (+)-alpha-(2,3-dimethoxi-phenyl)-1-[2-(4-fluoric-phenyl)-ethyl]-4-piperidine-methanole
BR9814923A (pt) Método para tratamento de doença de alzheimer
ES2178157T3 (es) Tratamiento de arritmias mediante la inhibicion de una proteina quinasa multifuncional dependiente de calcio/calmodulina.
AU3611299A (en) Use of metalloprotinease inhibitors for inducing and/or stimulating growth of hair or hairs and/or for slowing down their loss
WO1998026770A3 (en) The topical use of kappa opioid agonists to treat ocular pain
MY118986A (en) Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
GB2274777B (en) Synergistic combination of compounds having an antagonist effect on nk1 and on nk2 receptors
DE69934689D1 (de) Verwendung der protein-kinase-c-epsilon-inhibitoren zur behandlung von schmerzen
SE9503476D0 (sv) New combination
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
PL312198A1 (en) Application of procaine in obtaining a pharmaceutical preparation of analgesic activity with minimum motorial blocking effect
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas
AU6846300A (en) Use of cyamemazine for cold turkey benzodiazepine treatment
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
BR9708037A (pt) Método para o tratamento de abuso de substância
AU5816396A (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
BG105289A (en) The use of r(+)-alpha-(2,3-dimethoxyphenyl)-1-[2- (4-fluorophenyl)ethyl]-4-pip eridinemethanol for the treatment of sleep disorders
DE69428276D1 (de) Insulinähnlicher wachstumfaktor ii als antitumormittel
AU2001277273A1 (en) Methods and agents for treating persistent pain
BG100479U (en) Medicament for the local treatment of otitis
HK1059398A (en) Agents and methods for treating pain
MX9701528A (es) Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer.